TER Stock Analysis: Teradyne | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 57.778m USD | 12M Return: 308.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.06B
EPS Trend: 62.6%
Qual. Beats: 3
Rev. Trend: 70.0%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Teradyne, Inc. is a U.S.-based provider of automated test systems and robotics products, operating across the Americas, Asia Pacific, and EMEA through three main segments: Semiconductor Test, Robotics, and Other. The Semiconductor Test segment supplies wafer-level, device package, and system-level testing solutions for a wide range of end markets including automotive, industrial, communications, consumer electronics, smartphones, cloud computing, and gaming, serving integrated device manufacturers, fabless firms, foundries, and outsourced assembly and test providers. Key product lines include the FLEX test platform, J750 test system, Magnum memory test platform, and ETS analog/mixed-signal platform.
The Robotics segment offers collaborative robotic arms and autonomous mobile robots aimed at manufacturing, logistics, and industrial customers, while the Other segment covers defense/aerospace test, circuit-board test, wireless test systems, and silicon photonics testing. Teradyne has a strategic collaboration with Tokyo Electron Limited to develop test cell solutions for AI and data center applications, reflecting the growing importance of semiconductor test equipment in high-performance computing. Founded in 1960 and headquartered in North Reading, Massachusetts, the company operates within the Semiconductor Materials & Equipment industry, where automated test equipment (ATE) is a critical link in the semiconductor supply chain, validating chip functionality before deployment.
- AI data center chip testing demand accelerates Semiconductor Test bookings
- Robotics segment weakness pressures margins as Universal Robots orders decline
- Automotive chip electrification drives long-term test demand
| Net Income: 854.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -3.94 > 1.0 |
| NWC/Revenue: 30.66% < 20% (prev 38.08%; Δ -7.42% < -1%) |
| CFO/TA 0.18 > 3% & CFO 777.9m > Net Income 854.1m |
| Net Debt (-163.2m) to EBITDA (1.11b): -0.15 < 3 |
| Current Ratio: 2.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.6m) vs 12m ago -2.69% < -2% |
| Gross Margin: 58.79% > 18% (prev 59.36%; Δ -0.58% > 0.5%) |
| Asset Turnover: 93.05% > 50% (prev 78.41%; Δ 14.64% > 0%) |
| Interest Coverage Ratio: 67.68 > 6 (EBIT TTM 1.01b / Interest Expense TTM 14.9m) |
| A: 0.26 (Total Current Assets 2.17b - Total Current Liabilities 1.01b) / Total Assets 4.43b |
| B: 0.25 (Retained Earnings 1.12b / Total Assets 4.43b) |
| C: 0.25 (EBIT TTM 1.01b / Avg Total Assets 4.07b) |
| D: 2.44 (Book Value of Equity 3.14b / Total Liabilities 1.29b) |
| Altman-Z'' = 6.76 = AAA |
| DSRI: 1.85 (Receivables 1.11b/460.4m, Revenue 3.79b/2.91b) |
| GMI: 1.01 (GM 59.36% / 58.79%) |
| AQI: 0.99 (AQ_t 0.36 / AQ_t-1 0.36) |
| SGI: 1.30 (Revenue 3.79b / 2.91b) |
| TATA: 0.02 (NI 854.1m - CFO 777.9m) / TA 4.43b) |
| Beneish M = -2.11 (Cap -4..+1) = BB |
As of July 06, 2026, the stock is trading at USD 369.09 with a total of 5,938,000 shares traded. Over the past week, the price has changed by -21.80%, over one month by +3.12%, over three months by +17.06% and over the past year by +308.47%.
Current recommended Stop Loss: 319.30 (which is 13.5% or 1.4 ATR below the current price).
Teradyne has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy TER.
- StrongBuy: 9
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 416.7 | 12.9% |
P/E Trailing = 68.4768
P/E Forward = 52.356
P/S = 15.2576
P/B = 18.3783
P/EG = 1.4604
Revenue TTM = 3.79b USD
EBIT TTM = 1.01b USD
EBITDA TTM = 1.11b USD
Long Term Debt = 64.0m USD (estimated: total debt 82.4m - short term 18.4m)
Short Term Debt = 18.4m USD (from shortTermDebt, last quarter)
Debt = 82.4m USD (from shortLongTermDebtTotal, last quarter) (leases 82.4m already included)
Net Debt = -163.2m USD (calculated: Debt 82.4m - CCE 245.6m)
Enterprise Value = 57.6b USD (57.8b + Debt 82.4m - CCE 245.6m)
Interest Coverage Ratio = 67.68 (Ebit TTM 1.01b / Interest Expense TTM 14.9m)
EV/FCF = 104.2x (Enterprise Value 57.6b / FCF TTM 553.2m)
FCF Yield = 0.96% (FCF TTM 553.2m / Enterprise Value 57.6b)
FCF Margin = 14.61% (FCF TTM 553.2m / Revenue TTM 3.79b)
Net Margin = 22.55% (Net Income TTM 854.1m / Revenue TTM 3.79b)
Gross Margin = 58.79% ((Revenue TTM 3.79b - Cost of Revenue TTM 1.56b) / Revenue TTM)
Gross Margin QoQ = 60.89% (prev 57.49%)
Tobins Q-Ratio = 12.99 (Enterprise Value 57.6b / Total Assets 4.43b)
Interest Expense / Debt = 18.04% (Interest Expense 14.9m / Debt 82.4m)
Taxrate = 13.40% (132.8m / 991.5m)
NOPAT = 871.3m (EBIT 1.01b * (1 - 13.40%))
Current Ratio = 2.15 (Total Current Assets 2.17b / Total Current Liabilities 1.01b)
Debt / Equity = 0.03 (Debt 82.4m / totalStockholderEquity, last quarter 3.14b)
Debt / EBITDA = -0.15 (Net Debt -163.2m / EBITDA 1.11b)
Debt / FCF = -0.30 (Net Debt -163.2m / FCF TTM 553.2m)
Total Stockholder Equity = 2.87b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.99% (Net Income 854.1m / Total Assets 4.43b)
RoE = 29.72% (Net Income TTM 854.1m / Total Stockholder Equity 2.87b)
RoCE = 34.25% (EBIT 1.01b / Capital Employed (Equity 2.87b + L.T.Debt 64.0m))
RoIC = 26.80% (NOPAT 871.3m / Invested Capital 3.25b)
WACC = 14.67% (E(57.8b)/V(57.9b) * Re(14.67%) + D(82.4m)/V(57.9b) * Rd(18.04%) * (1-Tc(0.13)))
Discount Rate = 14.67% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -64.44 | Cagr: -1.24%
[DCF] Terminal Value 54.74% ; FCFF base≈575.3m ; Y1≈533.6m ; Y5≈482.3m
[DCF] Fair Price = 24.95 (EV 3.74b - Net Debt -163.2m = Equity 3.91b / Shares 156.5m; r=14.67% [WACC]; 5y FCF grow -9.08% → 2.50% )
EPS Correlation: 62.57 | EPS CAGR: 14.32% | SUE: 3.49 | # QB: 3
Revenue Correlation: 69.95 | Revenue CAGR: 7.96% | SUE: 1.88 | # QB: 3
EPS current Quarter (2026-06-30): EPS=2.05 | Chg30d=+0.61% | Revisions=+25% | Analysts=16
EPS next Quarter (2026-09-30): EPS=1.44 | Chg30d=+4.30% | Revisions=+25% | Analysts=16
EPS current Year (2026-12-31): EPS=7.29 | Chg30d=+2.09% | Revisions=+17% | GrowthEPS=+84.0% | GrowthRev=+41.0%
EPS next Year (2027-12-31): EPS=9.84 | Chg30d=+3.71% | Revisions=+25% | GrowthEPS=+35.0% | GrowthRev=+23.5%
[Analyst] Revisions Ratio: +44% (up=5, down=1)